CARLSBAD, Calif., June 29, 2017 /PRNewswire/ -- Natural
Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading
formulator, manufacturer and marketer of customized nutritional
supplements, announced today that it has extended to 2026 its
worldwide license agreement directed to NAI's CarnoSyn®
beta-alanine patent and trademark estate with Nutrabolt, LLC.
Nutrabolt is the fastest growing nutritional life
science company and creator of Cellucor® C4 products, the #1
pre-workout product offering in the market. The companies are
expanding their business relationship to collaborate in the area of
sports nutrition and other key fields of growth related to
CarnoSyn® beta-alanine. NAI owns an extensive
global IP portfolio covering its CarnoSyn® beta-alanine
and SR CarnoSyn® products and has invested significant
monies funding research and brand awareness around the world.
Nutrabolt is an industry leader in the area of sports
nutrition. Its predominance in the congested, pre-workout
market is unrivaled and offers consumers the most effective "best
in class" products. Nutrabolt's investment in sports
nutrition has led to significant business growth and expansion,
including the recent acquisition of Scivation Nutrition.
NAI also announced that the U.S. Patent and Trademark Office has
allowed a new patent application directed to a broad range of
improved methods of beta-alanine intake, targeting such benefits as
delaying muscle fatigue, increasing anaerobic capacity, increasing
muscle strength and increasing muscle endurance. This new
intellectual property significantly lengthened the patent coverage
for CarnoSyn® beta-alanine. Nutrabolt, given its
market dominance and view of the future of nutrition, was a natural
business partner for NAI. After months of substantive discussions
regarding NAI's intellectual property and the future vision of
nutrition in sports and other fields, the parties agreed to combine
their efforts to lead the market in future research, development
and sales of products using NAI's patented and trademarked
CarnoSyn® beta-alanine.
Mark A. LeDoux, NAI's CEO and
Chairman of the Board, said that "NAI is very excited by the
execution of this agreement with Nutrabolt extending its worldwide
license to our CarnoSyn® patent and trademark rights. The recent
addition of NAI's new patent, directed to a broad range of improved
methods of beta-alanine intake, is the future of beta-alanine in
sports nutrition." LeDoux went on to say that "during our
meetings with Nutrabolt executives and its research team, we
explored other fields of use for CarnoSyn® that NAI holds patent
rights to uses beyond sports nutrition and for which it continues
to explore through funded research around the world. The
opportunity to work with a market leader like Nutrabolt related to
CarnoSyn® was an easy decision for us."
NAI, headquartered in Carlsbad,
California, is a leading formulator, manufacturer and
marketer of nutritional supplements and provides strategic
partnering services to its customers. NAI's comprehensive
partnership approach offers a wide range of innovative nutritional
products and services to NAI's clients including scientific
research, clinical studies, proprietary ingredients,
customer-specific nutritional product formulation, product testing
and evaluation, marketing management and support, packaging and
delivery system design, regulatory review and international product
registration assistance. For more information about NAI, please see
its website at http://www.nai-online.com or
http://www.carnosyn.com.
This press release contains forward-looking statements within
the meaning of applicable securities laws that are not historical
facts and information. These statements represent our intentions,
expectations and beliefs concerning future events, including, among
other things, our expectations and beliefs with respect to our
future financial and operating results, the outcome of pending
litigation, the continued validity of our patents, and our ability
to successfully develop, license and enforce our intellectual
property rights. We wish to caution readers these statements
involve risks and uncertainties that could cause actual results and
outcomes for future periods to differ materially from any
forward-looking statement or views expressed herein. NAI's
financial performance and the forward-looking statements contained
herein are further qualified by other risks including those set
forth from time to time in the documents filed by us with the
Securities and Exchange Commission, including our most recent
Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
CONTACT – Michael Fortin, Chief
Financial Officer, Natural Alternatives International, Inc., at
760-736-7700 or investor@nai-online.com.
Web site: http://www.nai-online.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/natural-alternatives-international-inc-announces-extension-of-carnosyn-beta-alanine-license-agreement-with-nutrabolt-llc-300481647.html
SOURCE Natural Alternatives International, Inc.